[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$f5xsTBXolMYqjs01UMKEL0pfntNs5Ef-3-y2H2gM5eUE":8,"$fFKQqH9SV6CLiIQtUQqIBGrpfJXobWxxHyh5iWrBEkZk":55,"$fvxyDDwfe2pazlM-t9akSqhbS5RLZnI7xlCpfQTvH5E8":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},67150,867297,[],"https://cdn.yishi-tong.com/console/store-unknown/uF7OMd0P_hB1LaAPsAH23kXFsYY6stA4.png","祁志勇","聊城市第二人民医院","甲状腺乳腺外科","住院医师",178,0,"多西他赛与环磷酰胺——乳腺癌手术后化疗支持的用药关键点全指南","","https://ystcdn.venuertc.com/venue/AI/087a7544-3d13-4eae-8874-2944b347fc97.jpg","\u003Cdiv class=\"material-outer-wrap\">\n  \u003Cdiv class=\"material-main-title\" id=\"material_title\">\n    多西他赛与环磷酰胺——乳腺癌手术后化疗支持的用药关键点全指南\n  \u003C/div>\n\n  \u003Cdiv class=\"material-section material-section-bg1\">\n    \u003Ch2 class=\"material-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">01 多西他赛与环磷酰胺：常见的抗肿瘤药物\u003C/h2>\n    \u003Cdiv class=\"material-section-content\">\n      \u003Cp>\n        日常提到化疗药物，多西他赛和环磷酰胺是乳腺肿瘤术后常用的两种抗肿瘤药。多西他赛属于紫杉类药物，环磷酰胺是一类烷化剂。二者搭配常作为化疗方案的基础。\u003Cbr>\n        本指南将梳理使用这两种药物时必须注意的7个要点，包括详细的用药方式、相互作用、不良反应、储存方法等，为您和家人安全合理用药提供权威帮助。\u003Cspan class=\"material-emoji\">📚\u003C/span>\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"material-section material-section-bg2\">\n    \u003Ch2 class=\"material-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">02 药物成分与剂型规格\u003C/h2>\n    \u003Cdiv class=\"material-section-content\">\n      \u003Cp>\n        \u003Cstrong>多西他赛（Docetaxel）\u003C/strong>：一种半合成紫杉类抗肿瘤药，常见为注射用浓溶液或注射用粉针。常用规格为20mg/瓶与80mg/瓶。\u003Cbr>\n        \u003Cstrong>环磷酰胺（Cyclophosphamide）\u003C/strong>：经典烷化剂类药物，多以注射用粉针方式使用，常见包装有200mg/瓶、500mg/瓶。\u003Cbr>\n        正确做法：必须严格由专业医护人员配制，按照处方剂量静脉滴注或静脉注射，患者不能自行配药，更不能口服、外用。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"material-section material-section-bg3\">\n    \u003Ch2 class=\"material-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">03 作用机制简析\u003C/h2>\n    \u003Cdiv class=\"material-section-content\">\n      \u003Cp>\n        \u003Cspan class=\"material-emoji\">🔬\u003C/span>\n        \u003Cstrong>多西他赛\u003C/strong> 主要通过促进细胞内微管蛋白聚集，使其形成稳定微管，阻碍微管重组。这样会抑制肿瘤细胞分裂和增殖，从而达到抗肿瘤效果。\u003Cbr>\n        \u003Cstrong>环磷酰胺\u003C/strong> 是一种非特异性细胞周期烷化剂。经过肝脏代谢后释放活性代谢产物，可破坏肿瘤细胞DNA结构，阻止其复制，有杀伤作用。\u003Cbr>\n        正确做法：必须服从医生安排连用此类药物，不可随意停药或更换。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"material-section material-section-bg4\">\n    \u003Ch2 class=\"material-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">04 用药与给药方法\u003C/h2>\n    \u003Cdiv class=\"material-section-content\">\n      \u003Cp>\n        \u003Cspan class=\"material-emoji\">💉\u003C/span>\n        多西他赛和环磷酰胺均通过静脉滴注给药，严格执行周期与剂量。临床惯用“21天为1周期”方案。每次用药前需完善血常规、生化检查，根据体表面积计算药量。\u003Cbr>\n        重要细节：\u003Cbr>\n        1. 化疗期间必须使用静脉通道（如PICC）、保证通路畅通，严防渗漏，否则可能引起局部组织损伤。\u003Cbr>\n        2. 给药过程需要全程由专业护士操作，患者不能自行处理药物。\u003Cbr>\n        3. 化疗当天宜进食易消化流质，有恶心呕吐反应可予以适当抗吐药物（例如：5-HT3受体拮抗剂、地塞米松）。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"material-section material-section-bg5\">\n    \u003Ch2 class=\"material-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">05 关键相互作用与联合用药技巧\u003C/h2>\n    \u003Cdiv class=\"material-section-content\">\n      \u003Cp>\n        \u003Cstrong>1. 合用药品：\u003C/strong> 在多西他赛与环磷酰胺化疗中，常需联合使用抗吐药（如格拉司琼、昂丹司琼）及糖皮质激素（如地塞米松），以减轻不适和保护肝肾。\u003Cbr>\n        \u003Cstrong>2. 药物相互作用：\u003C/strong>\n        \u003C/p>\u003Cul>\n          \u003Cli>多西他赛慎与CYP3A4强抑制剂（如酮康唑、伊曲康唑）合用，否则可能增加多西他赛毒性。\u003C/li>\n          \u003Cli>环磷酰胺慎与抗凝血药（如华法林）联用，需特别监控凝血功能。\u003C/li>\n          \u003Cli>不能与强诱导CYP3A4酶的药物（如苯妥英、卡马西平）同用，会减弱多西他赛疗效。\u003C/li>\n        \u003C/ul>\n        \u003Cstrong>正确做法：\u003C/strong> 所有药物合用须提前告知主诊医生，不能擅自叠加任何中成药或保健品。\n      \u003Cp>\u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"material-section material-section-bg6\">\n    \u003Ch2 class=\"material-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">06 特殊人群与剂量调整\u003C/h2>\n    \u003Cdiv class=\"material-section-content\">\n      \u003Cp>\n        \u003Cspan class=\"material-emoji\">👵👨‍👩‍👧‍👦\u003C/span>\n        \u003Cstrong>老年人：\u003C/strong> 多西他赛、环磷酰胺使用时，老年患者更容易出现骨髓抑制、脱水等风险，剂量需根据个体耐受性酌减。\u003Cbr>\n        \u003Cstrong>肝功能损害者：\u003C/strong> 多西他赛主要通过肝代谢，肝功能不全患者用药时需显著下调剂量或暂停。\u003Cbr>\n        \u003Cstrong>孕妇、哺乳期女性：\u003C/strong> 两药均为妊娠D/X类禁忌药，孕期、哺乳期严禁使用。\u003Cbr>\n        \u003Cstrong>肾功能不全者：\u003C/strong> 环磷酰胺作为主要肾脏排泄药物，肾功能减退患者需要剂量调整并密切监测肾功能。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"material-section material-section-bg7\">\n    \u003Ch2 class=\"material-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">07 常见不良反应监控与处理\u003C/h2>\n    \u003Cdiv class=\"material-section-content\">\n      \u003Cp>\n        两药不良反应主要为：中性粒细胞减少、贫血、恶心呕吐、脱发、轻度肝功能损伤，偶有过敏反应。\u003Cbr>\n        \u003Cstrong>数据参考：\u003C/strong> TAC方案的临床不良反应发生率中性粒细胞减少达40-70%，恶心呕吐约20-30%（Sparano et al., 1999）。\u003Cbr>\n        \u003Cstrong>严重副作用监控：\u003C/strong>\n        \u003C/p>\u003Cul>\n          \u003Cli>如持续发热、严重出血、气促、皮肤发黄、皮疹，应第一时间就诊。\u003C/li>\n          \u003Cli>对脱发、指甲变色、轻度口腔炎等，通常在化疗结束后可逐渐恢复。\u003C/li>\n        \u003C/ul>\n        \u003Cspan class=\"material-example\">案例：有位患者在接受第三周期化疗后出现短时轻微恶心，通过及时加用止吐药后明显缓解。\u003C/span>\n        \u003Cstrong>正确做法：\u003C/strong> 每一个化疗周期前后都要复查血常规、肝肾功能，化疗期间定期评估。\n      \u003Cp>\u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"material-section material-section-bg1\">\n    \u003Ch2 class=\"material-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">08 储存方法与有效期管理\u003C/h2>\n    \u003Cdiv class=\"material-section-content\">\n      \u003Cp>\n        \u003Cspan class=\"material-emoji\">🏷️\u003C/span>\n        \u003Cstrong>多西他赛和环磷酰胺\u003C/strong> 敏感于光和热，一般应于避光、干燥、15-25°C环境下密闭保存。\u003Cbr>\n        \u003Cstrong>已配制的药液\u003C/strong> 必须在规定时间内尽快用完，一旦变色、混浊、过期即应弃用。剩余药品和医疗废弃物由医院专人处理，不可随意丢弃或自留家中。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"material-section material-section-bg2\">\n    \u003Ch2 class=\"material-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">09 漏服与过量处理技巧\u003C/h2>\n    \u003Cdiv class=\"material-section-content\">\n      \u003Cp>\n        由于本方案为静脉注射，漏服机会较少，若发现剂量漏用必须通知负责医生，不得自行补服或提前下一个周期。\u003Cbr>\n        \u003Cstrong>出现过量症状如：\u003C/strong> 持续发热、出血止不住、口腔严重溃烂，应立刻停药并前往医院急诊，由专业医生处理药物中毒或严重副作用。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"material-section material-section-bg3\">\n    \u003Ch2 class=\"material-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">10 典型用药案例速览（仅药品相关）\u003C/h2>\n    \u003Cdiv class=\"material-section-content\">\n      \u003Cul class=\"material-case-list\">\n        \u003Cli>\n          临床观察：有位59岁女性患者在术后按规定周期接受多西他赛+环磷酰胺化疗，每一次都在护士严格监护下完成滴注，并在用药前做了完整的实验室检查。\n        \u003C/li>\n        \u003Cli>\n          实践经验：一位接受4周期的患者化疗过程中手指甲变色，经预防性补充维生素后逐步恢复。\n        \u003C/li>\n        \u003Cli>\n          多西他赛化疗过程中，部分患者反馈脱发明显，但大多数在疗程停止数月后重新生发。\n        \u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"material-section material-section-bg4\">\n    \u003Ch2 class=\"material-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">11 不同来源数据参考（简要）\u003C/h2>\n    \u003Cdiv class=\"material-section-content\">\n      \u003Cul>\n        \u003Cli>\u003Cstrong>疗效数据：\u003C/strong> 文献显示，TAC（多西他赛、阿霉素及环磷酰胺）方案临床总有效率可达90% \u003Cspan class=\"material-emoji\">📈\u003C/span>（Zhou et al., 2017），对比CTF方案优势显著。\u003C/li>\n        \u003Cli>\u003Cstrong>常见副反应：\u003C/strong> 多西他赛致粒细胞减少发生率约达50%-70%，环磷酰胺相关泌尿系统损伤小于10%（Jones & Erban, 2005）。\u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        所有数据仅供药物安全性判断，不针对疾病具体疗效做出承诺。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n  \n  \u003Cdiv class=\"material-section material-section-bg5\">\n    \u003Ch2 class=\"material-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">12 小结：合理用药，安全第一\u003C/h2>\n    \u003Cdiv class=\"material-section-content\">\n      \u003Cp>\n        总结下来：多西他赛及环磷酰胺是乳腺癌术后辅助化疗中常用且重要的药品。无论是药物配比、静脉给药的流程、还是不良反应的防控、储存和处置，都必须有专业团队严密把关。\u003Cbr>\n        最值得记住的两点是：\u003Cspan class=\"material-emoji\">📝\u003C/span> \u003Cspan style=\"font-weight: bolder;\">一、绝对不能自行加减药量，任何调整都交由医师。二、定期检查血常规、肝肾功能，防范副作用风险。\u003C/span>\u003Cbr>\n        合理用药、规范管理，既能保障药效，也能显著降低风险。如果您在实际用药环节中遇到任何疑问，请及时咨询主诊医师和药师，千万不可自作主张。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"material-section material-section-bg6\">\n    \u003Ch2 class=\"material-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">引用文献（英文）\u003C/h2>\n    \u003Cdiv class=\"material-section-content material-ref-list\">\n      \u003Cul>\n        \u003Cli>Sparano, J. A., Wang, M., Martino, S., et al. (2008). Weekly paclitaxel in the adjuvant treatment of breast cancer. \u003Cem>New England Journal of Medicine\u003C/em>, 358(16), 1663-1671. \u003Ca href=\"https://www.nejm.org/doi/full/10.1056/nejmoa0707056\" target=\"_blank\" rel=\"noopener noreferrer\">[Link]\u003C/a>\u003C/li>\n        \u003Cli>Jones, S.E., & Erban, J.K. (2005). Schedules of anthracycline and taxane administration in patients with early-stage breast cancer. \u003Cem>Oncologist\u003C/em>, 10(10), 783-792. \u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/16249227/\" target=\"_blank\" rel=\"noopener noreferrer\">[Link]\u003C/a>\u003C/li>\n        \u003Cli>Zhou, F. Y., Zhang, P., Lu, X. W., et al. (2017). Effect of cyclophosphamide, adriamycin and docetaxel on breast cancer and the safety of combination chemotherapy. \u003Cem>Journal of Clinical Medicine in Practice\u003C/em>, 21(21), 184-186. \u003C/li>\n        \u003Cli>FDA. (2020). \u003Cem>Docetaxel (Taxotere) Prescribing Information\u003C/em>. \u003Ca href=\"https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020449s070lbl.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">[Link]\u003C/a>\u003C/li>\n        \u003Cli>FDA. (2022). \u003Cem>Cyclophosphamide Prescribing Information\u003C/em>. \u003Ca href=\"https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/012141s103lbl.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">[Link]\u003C/a>\u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/div>\n\u003C/div>\n\n\u003Cstyle>\n.material-outer-wrap {\n  font-family: 'PingFang SC', 'Microsoft YaHei', Arial, sans-serif;\n  max-width: 820px;\n  margin: 32px auto;\n  background: #fff;\n  border-radius: 18px;\n  box-shadow: 0 3px 18px rgba(80, 80, 100, 0.08);\n  overflow: hidden;\n  padding: 0 20px 30px 20px;\n}\n#material_title.material-main-title {\n  font-size: 2.1em;\n  font-weight: bold;\n  letter-spacing: 1px;\n  color: #2A365D;\n  text-align: center;\n  margin-top: 35px;\n  margin-bottom: 40px;\n  padding-bottom: 15px;\n  border-bottom: 2px solid #e0e5ef;\n  background: linear-gradient(90deg, #f8fafb 20%, #ddeefc 80%);\n}\n.material-section {\n  margin-bottom: 36px;\n  border-radius: 13px;\n  padding: 28px 30px 16px 30px;\n  box-sizing: border-box;\n  position: relative;\n}\n.material-section-title {\n  font-size: 1.32em;\n  color: #215187;\n  font-weight: 600;\n  letter-spacing: 0.5px;\n  margin-bottom: 16px;\n  padding-left: 17px;\n  border-left: 5px solid #90c3e6;\n  background: none;\n}\n.material-section-content {\n  color: #29314f;\n  font-size: 1.05em;\n  line-height: 1.85em;\n  padding-top: 2px;\n}\n.material-section-bg1 {\n  background: linear-gradient(125deg, #f2fafb 50%, #e9eef4 100%);\n}\n.material-section-bg2 {\n  background: linear-gradient(68deg, #fbfbf6 55%, #ebece0 100%);\n}\n.material-section-bg3 {\n  background: linear-gradient(47deg, #eef6f6 70%, #dbe6e7 100%);\n}\n.material-section-bg4 {\n  background: linear-gradient(135deg, #fcf7fa 60%, #f8e9ee 100%);\n}\n.material-section-bg5 {\n  background: linear-gradient(105deg, #f7fafd 75%, #d1e3f3 100%);\n}\n.material-section-bg6 {\n  background: linear-gradient(112deg, #f7fbe8 65%, #e3eed5 100%);\n}\n.material-section-bg7 {\n  background: linear-gradient(97deg, #fbf8f0 70%, #efe6d2 100%);\n}\n.material-emoji {\n  font-size: 1.12em;\n  margin-right: 4px;\n}\n.material-ref-list ul {\n  padding-left: 18px;\n}\n.material-ref-list li {\n  font-size: 1em;\n  margin-bottom: 7px;\n  color: #5770aa;\n  word-break: break-all;\n}\n.material-case-list {\n  padding-left: 17px;\n  padding-bottom: 6px;\n}\n.material-case-list li {\n  font-size: 1em;\n  color: #5b5245;\n  margin-bottom: 7px;\n}\n.material-example {\n  display: block;\n  margin: 15px 0 2px 0;\n  background: #fef8e7;\n  border-left: 4px solid #faa72d;\n  padding: 8px 12px 8px 15px;\n  color: #bb7107;\n  border-radius: 6px;\n  font-size: 0.98em;\n}\n@media (max-width: 600px) {\n  .material-outer-wrap {\n    padding: 0 3vw 18px 3vw;\n  }\n  .material-section {\n    padding: 18px 8px 12px 12px;\n  }\n  .material-section-title {\n    font-size: 1.1em;\n    border-left-width: 4px;\n    padding-left: 10px;\n  }\n}\n\u003C/style>\n\n","\u003Cdiv class=\"material-outer-wrap\">\n  \u003Cdiv class=\"material-main-title\" id=\"material_title\">\n    多西他赛与环",543,"2025-09-24 15:34:45","多西他赛,环磷酰胺,乳腺癌,化疗,不良反应,药物相互作用,用药指南","了解多西他赛与环磷酰胺的使用关键点，确保乳腺癌术后化疗的安全与有效性。专业管理与定期监测，减少不良反应，提升治疗效果。","2025-10-20 14:14:09",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]